Abstract:Abstract Background Hazard identification for risk assessment of nanoparticles (NPs) is mainly composed of in vitro cell-based assays and in vivo animal experimentation. The rapidly increasing number and functionalizations of NPs makes in vivo toxicity tests undesirable on both ethical and financial grounds, creating an urgent need for development of in vitro cell-based assays that accurately predict in vivo toxicity and facilitate safe nanotechnology. Methods In this study, we used 9 different NPs (CeO 2 , TiO 2 , carbon black, SiO 2 , NiO, Co 3 O 4 , Cr 2 O 3 , CuO, and ZnO). As an in vivo toxicity endpoint, the acute lung inflammogenicity in a rat instillation model was compared with the in vitro toxicity endpoints comprising cytotoxicity, pro-inflammatory cytokine expression, or haemolytic potential. For in vitro assays, 8 different cell-based assays were used including epithelial cells, monocytic/macrophage cells, human erythrocytes, and combined culture. Results ZnO and CuO NPs acting via soluble toxic ions showed positive results in most of assays and were consistent with the lung inflammation data. When compared in in vitro assays at the same surface area dose (30 cm 2 /mL), NPs that were low solubility and therefore acting via surface reactivity had no convincing activity, except for CeO 2 NP. Cytotoxicity in differentiated peripheral blood mononuclear cells was the most accurate showing 89% accuracy and 11% false negativity in predicting acute lung inflammogenicity. However, the haemolysis assay showed 100% consistency with the lung inflammation if any dose, having statistical significance was considered positivity. Other cell-based in vitro assays showed a poorer correlation with in vivo inflammogenicity. Conclusions Based on the toxicity mechanisms of NPs, two different approaches can be applied for prediction of in vivo lung inflammogenicity. Most in vitro assays were good at detecting NPs that act via soluble ions (i.e., ZnO and CuO NP). However, in vitro assays were limited in detecting NPs acting via surface reactivity as their mechanism of toxicity, except for the haemolysis assay.

Prediction of acute inhalation toxicity using cytotoxicity data from human lung epithelial cell lines

QSAR Study on Toxicity of Chemical Components of Chinese Materia Medica and Acute Toxicity of Rats

A new approach for risk assessment of pulmonary toxicants: a preliminary study using didecyldimethylammonium chloride

A novel in vitro high-content imaging assay for the prediction of drug-induced lung toxicity

ADMET Evaluation in Drug Discovery. Part 17: Development of Quantitative and Qualitative Prediction Models for Chemical-Induced Respiratory Toxicity.

Inhalation Toxicity Screening of Consumer Products Chemicals using OECD Test Guideline Data-based Machine Learning Models

In Silico Prediction of Chemical Acute Oral Toxicity Using Multi-Classification Methods

Predicting Organ Toxicity Using &Itin Vitro&It Bioactivity Data And Chemical Structure

New Approach Methodology for Assessing Inhalation Risks of a Contact Respiratory Cytotoxicant: Computational Fluid Dynamics-Based Aerosol Dosimetry Modeling for Cross-Species and In Vitro Comparisons

In Vitro Toxicity Screening of Fifty Complex Mixtures in HepG2 Cells

In vitro cytotoxicity assay with selected chemicals using human cells to predict target-organ toxicity of liver and kidney.

Predicting Organ Toxicity Using in Vitro Bioactivity Data and Chemical Structure.

In silico approaches in organ toxicity hazard assessment: Current status and future needs for predicting heart, kidney and lung toxicities

Predictive value of in vitro assays depends on the mechanism of toxicity of metal oxide nanoparticles

Application of general toxic effects of ionic liquids to predict toxicities of ionic liquids to Spodoptera frugiperda 9, Eisenia fetida, Caenorhabditis elegans, and Danio rerio

Development of a multi-analysis model using an epithelial-fibroblast co-culture system as an alternative to animal testing

Combined toxic effect of airborne heavy metals on human lung cell line A549

Quantitative Modeling of In Vitro Data Using an Adverse Outcome Pathway for the Risk Assessment of Decreased Lung Function in Humans

In Silico Prediction of Chemical Respiratory Toxicity Via Machine Learning

Establishment of a human induced pluripotent stem cell derived alveolar organoid for toxicity assessment

Theoretical Consideration on the Prediction of in Vivo Toxicity from in Vitro Toxicity: Effect of Bio-Uptake Equilibrium, Kinetics and Mode of Action